Hendrik Ruge

Showing 1-2 of 2 articles

Interventions for valvular disease

Clinical Experience with A Novel Large Bore Vascular Closure Device After Transfemoral TAVR

Ruge H, Erlebach M, Mayr P, Bleiziffer S, Lange R

September 24, 2019 | 10.4244/EIJ-D-19-00523

Interventions for valvular disease

Beyond the five-year horizon: long-term outcome of high-risk and inoperable patients undergoing TAVR with first-generation devices

Deutsch M-A, Erlebach M, Burri M, Hapfelmeier A, Witt OG, Ziegelmueller JA, Wottke M, Ruge H, Krane M, Piazza N, Bleiziffer S, Lange R

May 20, 2018 | 10.4244/EIJ-D-17-00603

1

Latest news

LM revascularisation, annulus rupture, risk stratification, renal denervation

EAPCI survey results: The impact of COVID-19

Marco Roffi, Dariusz Dudek, et al.

A perspective from EAPCI Women and Women as One

Gill Louise Buchanan

Last Update: CULPRIT, NOBEL, IVUS-XPL, SAFARI-STEMI

(supported by Biotronik)

Guidance Papers

Guidelines, consensus & position papers

EuroIntervention new Editorial Board

This week’s JAA’s: Paradigm Study: 12months outcome, GLASSY ACS vs SIHD...

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke